The DOI matches its Crossref record.
Editorial: Towards a global dengue research agenda
Open accessAbstract
Dengue is the most rapidly advancing vector-borne disease with an estimated 50 million dengue infections occurring annually (1, 2). As a result of major demographic changes, rapid urbanization on a massive scale, global travel and environmental change, the world – particularly the tropical world – faces enormous challenges from emerging infectious diseases. Dengue epitomizes these challenges. In the early years of the 21st century, we are collectively failing to meet the threat posed by dengue as the disease spreads unabated and almost 40% of the world's population now live at risk of contracting it. Because of the rapidly increasing public health importance of dengue, the 2002 World Health Assembly Resolution (WHA55.17) urged greater commitment among Member States and WHO to dengue control; of particular significance is the 2005 Revision of the International Health Regulations (WHA58.3), which includes dengue fever as an example of a disease that may constitute an international public health emergency. Countries or areas at risk of dengue transmission, 2006. Average annual number of DF/DHF cases reported to WHO and of countries reporting dengue. Dengue was incorporated in 1999 into the portfolio of the Special Programme for Research and Training in Tropical Diseases (TDR/WHO), leading to new and disease-endemic country (DEC) led research initiatives. Dengue vaccine discovery/development was taken up by the Initiative for Vaccine Research (IVR), another WHO-based department. New partners appeared on the scene: the Pediatric Dengue Vaccine Initiative (PDVI) and the Innovative Vector Control Consortium (IVCC), both financed by the Bill and Melinda Gates Foundation, and the Rockefeller Foundation. DENCO and DENFRAME, international consortia supported by the European Commission, were created to study dengue pathogenesis, clinical management and discovery of new diagnostics, and vector control. Concurrently, a TDR/PDVI international laboratory network is evaluating available and new dengue diagnostics, whereas TDR-supported multicentre studies on targeted vector interventions are exploring ways for more cost-effective vector control strategies (TDR 2005; Focks & Alexander 2006). IVR works with PDVI on standardized tools for vaccine evaluation. Industry has a renewed interest in product development in the areas of dengue vaccines, drugs, diagnostics and insecticide formulations for vector control. The Aedes genome has been sequenced and laboratory experiments with genetically transformed vectors are under way. Ecosystem-based interventions against the dengue vector are being analysed by TDR/IDRC- (International Development Research Centre, Canada) coordinated multicountry studies and clinical/pathophysiological studies are being conducted in Vietnam, Malaysia, Philippines and Thailand with support from the Wellcome Trust, UK, and the Armed Forces Research Institute of Medical Science (AFRIMS), Bangkok. These are examples of major research initiatives which are complemented by internally or externally financed studies and training activities in many dengue-endemic countries. At the same time, an Asian–Pacific Dengue Partnership is evolving; Mekong Delta countries are receiving support for dengue activities from the Asian Development Bank and the WHO Regional Office for the Western Pacific; and a new Strategy for Integrated Dengue Management in the American Region is being promoted. Guidelines for planning social mobilization and communication (Parks & Lloyd 2004) and clinical management (Kalayanarooj & Nimmannitya 2004; WHO 2006a), as well as dengue CD ROMs (Wellcome/TDR 2005; WHO 2006b) and other training materials have been published. Dengue Net, a web-based information system, has been established by WHO. Internationally renowned training courses are the biennial course in Cuba (10th anniversary in 2007) and the clinical management course in the Bangkok Children's Hospital. It was against this background that the Dengue Scientific Working Group of 60 experts from 20 countries including WHO staff from four Regions and headquarters met in Geneva in October 2006 to review existing knowledge on dengue and to establish priorities for future dengue research aimed at improving dengue treatment, prevention and control. The goal of the Scientific Working Group was to outline a research agenda by identifying potentially fruitful directions as well as key bottlenecks and making detailed and specific research recommendations. The SWG wanted to identify areas of research that could lead to tangible benefits for people in disease-endemic countries in the coming years as well as outline a strategic vision for applied and basic research from which benefits would be felt in the medium to long term. It was noted that there is currently no specific clinically useful diagnostic test, no drugs, no available vaccine, and that we have failed to widely or effectively implement existing vector control and clinical management measures t
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Guzman, M. G., Gubler, D. J., Izquierdo, A., Martinez, E., & Halstead, S. B. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.55 · Cited by 762
Self-citationGlobal spread of dengue virus types: mapping the 70 year history
Messina, J. P., Brady, O. J., Scott, T. W., Zou, C., Pigott, D. M., Duda, K. A., Bhatt, S., Katzelnick, L., Howes, R. E., Battle, K. E., et al. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2013.12.011 · Cited by 716
Self-citationCommunity involvement in dengue vector control: cluster randomised trial
Vanlerberghe, V, Toledo, M. E., Rodriguez, M., Gomez, D., Baly, A., Benitez, J. R., & Van der Stuyft, P. (2009) · BMJ · doi:10.1136/bmj.b1959 · Cited by 160
Community-based control of Aedes aegypti by adoption of eco-health methods in Chennai City, India
Arunachalam, N., Tyagi, B. K., Samuel, M., Krishnamoorthi, R., Manavalan, R., Tewari, S. C., Ashokkumar, V, Kroeger, A., Sommerfeld, J., & Petzold, M. (2012) · Pathogens and Global Health · doi:10.1179/2047773212y.0000000056 · Cited by 137
Self-citationVanlerberghe, V., Villegas, E., Oviedo, M., Baly, A., Lenhart, A., McCall, P. J., & Van der Stuyft, P. (2011) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000994 · Cited by 88
Self-citation
Metadata
- Authors
- Farrar, J., Focks, D., Gubler, D., Barrera, R., Guzman, M. G., Simmons, C., Kalayanarooj, S., Lum, L., McCall, P. J., Lloyd, L., Horstick, O., Dayal‐Drager, R., Nathan, M. B., Kroeger, A., & on behalf of the WHO/TDR Dengue Scientific Working Group
- Venue
- Tropical Medicine & International Health
- Publisher
- Wiley
- Published
- 2007-06
- Volume
- 12
- Issue
- 6
- Pages
- 695-699
- ISSN
- 1360-2276 (ISSN-L)
- 1365-3156
- OpenAlex
- W2160475351
- Cited by
- 159
- References
- 0
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Editorial: Towards a global dengue research agenda. https://app.cochat.ai/papers/10.1111/j.1365-3156.2007.01838.x
- The paper
- Farrar, J., Focks, D., Gubler, D., Barrera, R., Guzman, M. G., Simmons, C., Kalayanarooj, S., Lum, L., McCall, P. J., Lloyd, L., Horstick, O., Dayal‐Drager, R., Nathan, M. B., Kroeger, A., & on behalf of the WHO/TDR Dengue Scientific Working Group. (2007). Editorial: Towards a global dengue research agenda. Tropical Medicine & International Health. https://doi.org/10.1111/j.1365-3156.2007.01838.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.